Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement Disorders
暂无分享,去创建一个
Carlo Colosimo | Patrik Brundin | V. Fung | D. Burn | P. Brundin | C. Colosimo | U. Kang | S. Papa | Victor S C Fung | David J Burn | Stella M Papa | Un Jung Kang | Han-Lin Chiang | Roy N Alcalay | Claudia Trenkwalde | R. Alcalay | H. Chiang | Claudia Trenkwalde | C. Colosimo | Victor S C Fung | David J Burn | Patrik Brundin | Stella M Papa | Han-Lin Chiang
[1] J. Fleming,et al. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[2] Y. Sunden,et al. Vet Pathol 41:101–107 (2004) The Vagus Nerve is One Route of Transneural Invasion for , 2022 .
[3] G. Dunn,et al. Evidence for an enterovirus as the cause of encephalitis lethargica , 2012, BMC Infectious Diseases.
[4] A. Souza-Machado,et al. The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis. , 2012, Clinical therapeutics.
[5] S. Tisch,et al. Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[6] David K Meyerholz,et al. Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4 , 2015, The Journal of infectious diseases.
[7] B. Guthrie,et al. Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database , 2017, BMC Neurology.
[8] H. Yasunaga,et al. Influence of Parkinsonism on outcomes of elderly pneumonia patients. , 2018, Parkinsonism & related disorders.
[9] D. Wesson,et al. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases , 2016, Neurobiology of Disease.
[10] Z. Mari,et al. The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach , 2018, Current Neurology and Neuroscience Reports.
[11] L. Brundin,et al. Can infections trigger alpha-synucleinopathies? , 2019, Progress in molecular biology and translational science.
[12] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[13] NacotiMirco,et al. At the Epicenter of the Covid-19 Pandemic and Humanitarian Crises in Italy: Changing Perspectives on Preparation and Mitigation , 2020 .
[14] Quanyi Wang,et al. Viral load of SARS-CoV-2 in clinical samples , 2020, The Lancet Infectious Diseases.
[15] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[16] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[17] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[18] A. Wilder-Smith,et al. Can we contain the COVID-19 outbreak with the same measures as for SARS? , 2020, The Lancet Infectious Diseases.
[19] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[20] Tsutomu Hashikawa,et al. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients , 2020, Journal of medical virology.
[21] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[22] T. Hashikawa,et al. Response to Commentary on: "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients". , 2020, Journal of medical virology.
[23] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[24] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[25] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[26] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[27] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[28] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[29] Yan Bai,et al. Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.